Oncoloxía médica
Servicio
Royal Marsden Hospital
Londres, Reino UnidoPublicacións en colaboración con investigadores/as de Royal Marsden Hospital (5)
2021
-
Brigatinib Versus Crizotinib in ALK Inhibitor–Naive Advanced ALK-Positive NSCLC: Final Results of Phase 3 ALTA-1L Trial
Journal of Thoracic Oncology, Vol. 16, Núm. 12, pp. 2091-2108
-
Health-related quality of life in the randomized phase III trial of brigatinib vs crizotinib in advanced ALK inhibitor–naive ALK + non−small cell lung cancer (ALTA-1L)
Lung Cancer, Vol. 155, pp. 68-77
2020
2008
-
Phase III trial comparing paclitaxel poliglumex vs docetaxel in the second-line treatment of non-small-cell lung cancer
British Journal of Cancer, Vol. 98, Núm. 10, pp. 1608-1613